Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma - Volovitz,B.; Tabachnik,E.; Nussinovitch,M. (J Allergy Clin Immunol, 1999)